Learning Biology is an evolving process. The science keeps changing towards a greater understanding and sometimes the conclusions that were drawn are not always right. For example, blood letting or bleeding a person used to be the treatment for some diseases. That was an acceptable form of treatment but now we wonder as to what led to those conclusions? It is difficult to be just 100% right all the time. When a scientist makes a specific theory, it is based upon the data that is available at that time. If that data changes over the period or some new information comes in then the theory has to change. As scientists, we beat ourselves up on being right 100% of the time and if that is what we aim for then it would be impossible to conclude anything and we would just want to be quiet and live in a cave without concluding anything. However, the good scientists try’s to find the interesting (which may also vary) things in the world and work on them. There is another catch here: if they work on something that is just “cool” and has a lot of other scientists working on them, then there will be no differentiator. A good scientist will try to discover and work on interesting things to work on that are interesting to them and are cool but is the kind of thing that no one is paying much attention to…
Similar Posts
Bisphenol A
There is lot of information on BPA on wikipedia that talks about its use in plastics especially polycarbonates that are used in water bottle manufacturing. Polycarbonate bottles are transparent and can contain 90% BPA by mass It is not a plasticizer. The concern for its use comes from its effect as a weak xenoestrogen disrupting…
Cancer treatment targeting through bacteria
Dr Claudia Gravekamp from the Albert Einstein College of Medicine is exploring the treatment of cancer with bacteria after she observed that the bacteria, Listeria monocytogenes, seemed to be concentrating near the area of tumor. Tumor targeting of drugs or radiation is a very big issue. Currently, there are several drugs that attack cancer cells…
TDP43
TDP43 (a nuclear DNA-RNA binding protein) is involved in splicing, RNA transport and stability in neurons. It was first identified as a pyrimidine rich TAR DNA sequence in HIV type 1 gene to modulate HIV gene expression. In 95% of the ALS patients, TDP43 is abnormal located within the cell and may also be aggregated,…
Platform vs Product
In any Biotech company, there is always a promise of platform technology that enables it to produce many products. And investors and Biotech companies always consider which is the way to go – do they fund the developed of the Platform or the drug but it’s always a tossup between which is funded and which…
Provivi
Now that is an interesting company. An ability to control pests without killing them. https://provivi.com/en/the-science The company generates a pheromone that confuses the pests so that it cannot find its mate and that way is not able to reproduce. So it eventually dies and does not multiply. The unique thing about the company is the…
AI | Biology | Biomarker | PharmaceuticalBiotech companies
Small Biotechs: Diagonal Tx: Clustering antibodies that mimic the action of the ligand and bypass the need for the ligand and receptor. This mutation that is created makes standard AI models not useful and so need a new method. This restores new ALK1 signaling in Hereditary Hemorrhagic Telangiectasia. It also treates LoF mutations in ALK1…